EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Impact of Front‐of‐Pack Labeling on Social Inequality in Sugar Consumption and Purchase: A Systematic Review

Ziyao Ge, Claudia H. Marck, Adyya Gupta, Gagandeep Kaur, Roisin McGrath, Ankur Singh

Obesity Reviews · 2026-11 · 27 (11)

DOI: 10.1111/obr.70150 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objective This systematic review examined the impact of front‐of‐pack labeling (FOPL) on social inequality in sugar consumption and purchase. Methods We searched Ovid MEDLINE, Scopus, EMBASE, and Web of Science for studies published in English since 2005. Eligible studies included randomized controlled trials and observational studies. The screening was conducted independently by at least two reviewers. Data extraction and quality assessments were cross‐checked. The risk of bias was assessed using ROBINS‐E, RoB2, and CHEERS 2022. A narrative synthesis summarized the findings. Results Of the total of 7701 studies identified, 10 studies were included. All included studies were conducted in high‐ and upper‐middle‐income countries, and primarily evaluated one specific type of FOPL, specifically warning labels ( n = 8). All studies reported FOPL reduced sugar consumption at the population level. However, findings on social inequality were inconsistent. Five studies showed greater benefit among higher‐socioeconomic groups, four among lower‐socioeconomic groups, two identified a U‐shaped effect, and two found no differential effect by socioeconomic status. The overall quality of studies was poor. Discussion FOPL, in particular warning labels, can reduce sugar consumption, but its effects on socioeconomic inequalities were inconsistent. Evaluation of high‐quality longitudinal research is needed to ensure FOPL interventions are inclusive and effective across socioeconomic groups.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →